Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
Head of Rosatom Sergey Kiriyenko and Armenia's Minister of Energy and Natural Resources Yervand Zakharyan signed the deal.
Around 10.6% will be spent on economy, 7.2% will be used to repay Armenia's debts, 3.5% will go the communities as budget subsidies.
Samvel Karapetyan’s company confirmed the purchase of the Electric Networks of Armenia and Hrazdan thermal power plant.
“Power generating companies had been affected by the financial deficit in the Electric Networks of Armenia,” the company said.
Partner news